This indicates that there is a relationship between the p53-miR-19-SOX4 feedback loop and the oncogenic behavior of hepatocellular carcinoma cells, and miR-19 may have the potential to be used as a biological marker of HCC in clinical settings. Here, TP53 is linked to hepatocellular carcinoma.